Summary
In Parkinson’s disease, apoptosis was proposed to cause cell death in nigral dopamine neurons. An endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, stereo-selectively induced apoptosis in human neuroblastoma SH-SY5Y cells. In this paper the intracellular mechanism of apoptosis was studied using N-methyl(R)salsolinol, 6-hydroxydopamine and peroxynitrite as inducers of apoptosis. Apoptotic cascade was initiated by opening of mitochondrial permeability transition pore, as shown by collapse of mitochondrial membrane potential, AtPm. Apoptosis was executed by caspase 3 activation, followed by DNA fragmentation, which was antagonized by overexpressed Bc1-2. Propargylamines were found to protect the cells from apoptosis, and rasagiline, a selective irreversible inhibitor of type B monoamine oxidase was the most potent to prevent the cell death. Rasagiline preserved O’Pm, which was proved also in isolated mitochondria, and rasagiline completely suppressed the activation of caspases and DNA fragmentation. These results suggest that mitochondria regulate apoptotic process, which may be a target of neuroprotection by rasagiline.
References
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akao Y, Mizoguchi H, Kojima S, Naoe T, Ohishi N, Yagi K (1998) Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro; activation of caspases and down-regulation of Bc1–2 protein. Br J Hematol 102: 1–2
Akao Y, Nakagawa Y, Maruyama W, Takahashi T, Naoi M (1999) Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3. Neurosci Lett 267: 153–156
Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol Histopathol 12: 25–31
Bernardi P, Broekemereier KM, Pfeiffer DR (1994) Recent progress on regulation of the permeability transition pore, a cyclosporin A-sensitive pore in the mitochondrial inner membrane. J Bioenerg Biomembr 26: 509–517
Biangini G, Frasoldati A, Fuxe K, Agnati LF (1993) L-Deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain. NeuroReport 4: 955958
Burke RE, Kholodilox NG (1998) Programmed cell death: Does it play a role in Parkinson’s disease? Ann Neurol 44 (Suppl 1): S126–133
Bronzetti E, Felici L, Ferrante F, Vasecchi B (1992) Effect of ethylcholine mustard aziridinium (AF64A) and on monoamine oxidase-B-inhibitor L-deprenyl on the morphology of rat hippocampus. Int J Tissue React XIV: 175–182
Carrillo MC, Minami C, Kitani K, Maruyama W, Ohashi K, Yamamoto T, Naoi M, Kanai S, Youdium MBH (2000) Enhancing effect of rasagiline on superoxide dismutase (SOD) and catalase (CAT) activities in the dopaminergic system in the rat. Life Sci 67: 577–585
Chernyak BV, Bernardi P (1996) The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur J Biochem 238: 623–630
Cotman CW, Anderson AJ (1995) A potential role for apoptosis in neurodegeneration and Alzheimer’s disease. Mol Neurobiol 10: 19–45
Crow JP (1997) Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide: Biol Chem 1: 145–157
Dipasquale B, Marini AM, Youle RJ (1991) Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Commun 181: 14421448
Enari M, Sakahira H, Yokoyama O, Okawa K, Iwamatsu A, Nagata S (1998) A caspaseactivated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43–50
Finberg JPM, Tenne M, Youdim MBH (1981) Tyramine antagonistc properties of AGN 1135-an irrevesible inhibitor of monoamine oxidase type B. Br J Pharmacol 73: 65–74
Finberg JPM, Lamendorf I, Weinstock M, Schwartz M, Youdim MBH (1999) Pharmacology of rasagiline (N-propargyl-1R-aminoindan). Adv Neurol 80: 495–499
Finnegan KT, Skratt JJ, Irwin I, DeLanney LE, Langston JW (1990) Protection against DSP-4 induced neurotoxicity by deprenyl is not related to its inhibition of MAO B. Eur J Pharmacol 184: 119–126
Hara H, Friedlander RM, Gagliardini V, Ayata C, Frink K, Huang Z, Shimizu-Susamata, Yuan J, Moskowitz MA (1997) Inhibition of interleukin lb converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94: 2007–2112
Huang W, Chen Y, Shohami E, Weinstock W (1999) Neuroprotective effects of rasgiline, a selective monoamine oxiodase B inhibitor against closed head injury in mouse. Eur J Pharmacol 366: 127–135
Kalir A, Sabbagh A, Youdim MBH (1981) Selective acetylenic suicide and reversible inhibitors of monoamine oxidase type A and B. Br J Pharmacol 73: 55–64
Kroemer G, Petit PX, Zamzami N, Vayssiere J-L, Mignotte B (1995) The biochemistry of apoptosis. FASEB J 9: 1277–1287.
Lotharius J, Dugan LL, O’Mallet KL (1999) Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19: 1284–1293
Apoptosis in dopamine neurons and protection by rasagiline 185
Maruyama W, Naoi M (1998) N-Methyl(R)salsolinol: A neurotoxin candidate induce Parkinson’s disease causes apoptosis in dopamine cells. In: Fisher A, Hanin I, Yoshida M (eds) Progress in Alzheimer’s and Parkinson’s diseases. Plenum Press, New York, 105–111
Maruyama W, Abe T, Tohgi H, Dostert P, Naoi M (1996) A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian CSF. Ann Neurol 40: 119122
Maruyama W, Naoi M, Kasamatsu T, Hashizume Y, Kohda K, Dostert P (1997a) An endogenous dopaminergic neurotoxin, N-methyl-(R)salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells. J Neurochem 69: 322–329
Maruyama W, Strolin Benedetti M, Takahashi T, Naoi M (1997b) A neurotoxin N-methyl(R)salsolinol induces apoptotic cell death in differentiated human dopaminergic neuroblastoma SH-SY5Y cells. Neurosci Lett 232: 147–150
Maruyama W, Takahashi T, Naoi M (1998) (—)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide. J Neurochem 70: 2510–2515
Mochizuki H, Nakamura N, Nishi K, Mizuno Y (1994) Apoptosis induced by 1-methyl-4phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat. Neurosci Lett 170: 191–194
Mochizuki H, Goto G, Mori H, Mizuno Y (1996) Histochemical detection of apoptosis in Parkinson’s disease. J Neurol Sci 137: 120–123
Mytillineou C, Cohen G (1985) Deprenyl protects dopaminergic neurons from neurotoxic effects of 1-methyl-4-phenylpyridiniun ion. J Neurochem 45: 1951–1953
Naoi M, Maruyama W (1999) N-Methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson’s disease. Adv Neurol 80: 259–264
Naoi M, Maruyama W, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M (1996) Dopamine-derived endogenous 1(R), 2(N)-dimethyl-6,7-dihyroxy-1,2,3,4terahyroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rats: Biochemical, pathological and behavioral studies. Brain Res 709: 285–295
Naoi M, Maruyama W, Nakao N, Ibi T, Sahashi K, Strolin Benedetti M (1998) (R)Salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes. Ann Neurol 43: 212–216
Nicholson DW, Thornberry NA (1997) Caspases: killer proteases. TIBS 22: 299–306 Nunez G, Benedict MA, Hu Y, Inohara N (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17: 299–306
Oh-hashi K, Maruyama W, Yi H, Takahashi T, Naoi M, Isobe K (1999) Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. Biochem Biophys Res Comm 263: 5–4509
Oppenheim RW (1991) Cell death during development of the nervous system. Ann Rev Neurosci 14: 453–501
Pettmann B, Henderson CE (1998) Neuronal cell death. Neuron 20: 633–647
Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995) Evidence for apoptotic cell death in Huntington’s disease and excitotoxic animal models. J Neurosci 15: 3775–3787
Prezedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93: 45654571
Royall JA, Ischiropoulos (1993) Evaluation of 2’,7’-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys 302: 348–355
Salonen H, Haapalinna A, Heinonen E, Suhonen J, Hervonen A (1996) Monoamine oxidase B inhibitor selegiline protects young and aged rat peripheral sympathetic 186 W. Maruyama et al.: Apoptosis in dopamine neurons and protection by rasagiline neurons against 6-hydroxydopamine-induced neurotoxicity. Acta Neuropathol 91: 466–474
Schendel SL, Xie Z, Montai MO, Matsuyama S, Montai M, Reed JC (1997) Channel formation by antiapoptotic protein Bc1–2. Proc Natl Acad Sci USA 94: 1–2
Schulz JB, Weller M, Moskowitz MN (1999) Caspases as treatment targets in stroke and neurodegenerative disease. Ann Neurol 4: 421–429
Shimizu S, Narita M, Tsujimoto Y (1999) Bd-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483–491
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–507
Tatton NA, Kish SJ (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-pheny1–1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferease labeling and acridine orange staining. Neurosci 77: 1–1
Tatton WG, Ju WJH, Holland DP, Tai C, Kwan M (1994) (—)-Depreny reduced PC12 cell apoptosis by inducing new protein synthesis. J Neurochem 63: 1572–1575
Teitel S, O’Brien J, Waters CW (1972) Alkaloids in mammalian tissues. 2. Synthesis of (+) and (—)-1-substituted-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines. J Med Chem 15: 845–846
Thomas CE, Huber EW, Ohlweiler DF (1997) Hydroxyl and peroxy radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: Implication for protection of biological substrates. Free Rad Biol Med 22: 733–737
Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1462
Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts, and protein products of bc1–2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83: 1–2
Tsujimoto Y, Shimizu S (2000) Bc1–2 family: Life-death switch. FEBS Lett 00: 1–2
Walkinshaw G, Waters CM (1994) Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neurosci 63: 975–987
Youdim MBH, Wadia JS, Tatton WG (1999) Neuroprotective properties of the antiparkinson drug rasagiline and its optical S-isomer. Neurosci Lett 55: S45/
Ziv H, Melamed E, Nardi N, Luria D, Achiron A, Offen D, Barzilai A (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons-a possible novel pathogenic mechanism in Parkinson’s disease. Neurosci Lett 170: 176–140
Authors’ address: Dr. M. Naoi, Department of Brain Sciences, Institute of Applied Biochemistry, Yagi Memorial Park, Mitake, Gifu 505–0116, Japan. E-mail: mnaoi@quartz.ocn.ne.jp
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Wien
About this paper
Cite this paper
Maruyama, W., Akao, Y., Youdim, M.B., Naoi, M. (2000). Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022. In: Riederer, P., et al. Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6301-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6301-6_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83537-1
Online ISBN: 978-3-7091-6301-6
eBook Packages: Springer Book Archive